Bioelectrochemical stacks connected in series are limited by voltage reversal: layers with unequal current capacity cannot match the imposed current, reverse polarity, degrade further, and drive the stack into a positive-feedback collapse. Every reported mitigation is electronic (balancing resistors, per-cell converters) and is unavailable to a passive membrane stack such as a reverse-electrodialysis (RED) device. We propose and model an architecture in which the proton gradient of each layer is regenerated in situ by a living biofilm rather than supplied by an external salinity feed, and we ask whether biofilm growth provides negative feedback strong enough to overcome reversal. Using a coupled electrochemical–metabolic model (layer polarization, Monte Carlo over layer-to-layer variance, logistic biofilm dynamics, and flux-balance analysis of a curated core metabolic network) we find that a passive stack diverges, with the coefficient of variation across layers rising from 18.5% to 66% and power collapsing, whereas an otherwise identical living stack converges to 10.3% and retains power. Convergence holds whenever the reversal damage rate and the growth rate satisfy k_rev/μ_max ≲ 0.8, a ratio that is essentially invariant with μ_max. The residual variance is set by structural (fabrication) dispersion, not by inoculation dispersion, which growth erases entirely. After the deliberate killing of one layer the modelled stack recovers 95% of its power in 12.6 days while a passive control does not recover. Metabolic calibration reveals the governing trade-off: every proton diverted to the external circuit is a proton that does not pass ATP synthase, so power and growth compete for the same budget; and because activity falls with acidity, an optimal ΔpH exists near 1.5–1.6 rather than "as large as possible". We do not claim competitive power density — silicon photovoltaics outperform the photosynthetic front end by an order of magnitude in area — but rather a distinct operating regime characterised by self-levelling, self-repair and growth-based manufacture. We set out a falsifiable bench programme whose first experiment, the measurement of k_rev, can refute the central claim. This is a modelling study. No experimental data are reported. All code is included as supplementary material.
No takes yet. Share an insight, caveat, or question.
Gabriel Skura Ribeiro (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: